Published in Vaccine Weekly, August 16th, 2006
MICs are not eligible for benefits from many of the same policies, programs and agreements that promote antiretroviral treatment (ART) access in least developed countries (LDCs) where AIDS drug treatment can cost less that $200 annually per person.
As a result, in a middle-income country like Mexico, which has a per capita annual income of approx. $6,000, AIDS drugs for one person cost $8,000 annually.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.